Karen Acosta

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Transcription Factor

Top Venues

Science advances

NPJ Parkinson's disease

This page only lists publications with an associated author ORCID identifier.

Publications

Saranya Santhosh Kumar, Nima N Naseri, Sarshan R Pather, Erinc Hallacli, Alain Ndayisaba, Chris Buenaventura, Karen Acosta, Jennifer Roof, Hossein Fazelinia, Lynn A Spruce, Kelvin C Luk, Vikram Khurana, Elizabeth Rhoades, Ophir Shalem
Sequential CRISPR screening reveals partial NatB inhibition as a strategy to mitigate alpha-synuclein levels in human neurons. Science advances 10 (6) (2024)
Saranya Santhosh Kumar, Nima N Naseri, Sarshan R Pather, Erinc Hallacli, Alain Ndayisaba, Chris Buenaventura, Karen Acosta, Jennifer Roof, Hossein Fazelinia, Lynn A Spruce, Kelvin C Luk, Vikram Khurana, Elizabeth Rhoades, Ophir Shalem
Sequential CRISPR screening reveals partial NatB inhibition as a strategy to mitigate alpha-synuclein levels in human neurons. Science advances 10 (6) (2024)
Saranya Santhosh Kumar, Nima N Naseri, Sarshan R Pather, Erinc Hallacli, Alain Ndayisaba, Chris Buenaventura, Karen Acosta, Jennifer Roof, Hossein Fazelinia, Lynn A Spruce, Kelvin C Luk, Vikram Khurana, Elizabeth Rhoades, Ophir Shalem
Sequential CRISPR screening reveals partial NatB inhibition as a strategy to mitigate alpha-synuclein levels in human neurons. Science advances 10 (6) (2024)
Saranya Santhosh Kumar, Nima N Naseri, Sarshan R Pather, Erinc Hallacli, Alain Ndayisaba, Chris Buenaventura, Karen Acosta, Jennifer Roof, Hossein Fazelinia, Lynn A Spruce, Kelvin C Luk, Vikram Khurana, Elizabeth Rhoades, Ophir Shalem
Sequential CRISPR screening reveals partial NatB inhibition as a strategy to mitigate alpha-synuclein levels in human neurons. Science advances 10 (6) (2024)
Saranya Santhosh Kumar, Nima N Naseri, Sarshan R Pather, Erinc Hallacli, Alain Ndayisaba, Chris Buenaventura, Karen Acosta, Jennifer Roof, Hossein Fazelinia, Lynn A Spruce, Kelvin C Luk, Vikram Khurana, Elizabeth Rhoades, Ophir Shalem
Sequential CRISPR screening reveals partial NatB inhibition as a strategy to mitigate alpha-synuclein levels in human neurons. Science advances 10 (6) (2024)
Saranya Santhosh Kumar, Nima N Naseri, Sarshan R Pather, Erinc Hallacli, Alain Ndayisaba, Chris Buenaventura, Karen Acosta, Jennifer Roof, Hossein Fazelinia, Lynn A Spruce, Kelvin C Luk, Vikram Khurana, Elizabeth Rhoades, Ophir Shalem
Sequential CRISPR screening reveals partial NatB inhibition as a strategy to mitigate alpha-synuclein levels in human neurons. Science advances 10 (6) (2024)
Saranya Santhosh Kumar, Nima N Naseri, Sarshan R Pather, Erinc Hallacli, Alain Ndayisaba, Chris Buenaventura, Karen Acosta, Jennifer Roof, Hossein Fazelinia, Lynn A Spruce, Kelvin C Luk, Vikram Khurana, Elizabeth Rhoades, Ophir Shalem
Sequential CRISPR screening reveals partial NatB inhibition as a strategy to mitigate alpha-synuclein levels in human neurons. Science advances 10 (6) (2024)
Anthony R Braun, Elly E Liao, Mian Horvath, Prakriti Kalra, Karen Acosta, Malaney C Young, Noah Nathan Kochen, Chih Hung Lo, Roland Brown, Michael D Evans, William C K Pomerantz, Elizabeth Rhoades, Kelvin C Luk, Razvan L Cornea, David D Thomas, Jonathan N Sachs
Potent inhibitors of toxic alpha-synuclein identified via cellular time-resolved FRET biosensors. NPJ Parkinson's disease 7 (1) (2021)